Incidence trends of colorectal cancer in the early 2000s in Italy. Figures from the IMPATTO study on colorectal cancer screening

Epidemiologia e Prevenzione

Volumn 39, Issue 3, 2015, Pages 115-125

  Zorzi, Manuel ^a   Mangone, Lucia ^b,c   Sassatelli, Romano ^d,e   Baracco, Susanna ^a   Budroni, Mario ^f   Castaing, Marine ^g   Cirilli, Claudia ^h   Cusimano, Rosanna ⁱ   Fusco, Mario ^j   Giacomin, Adriano ^k   Rossi, Paolo Giorgi ^d,l   Naldoni, Carlo ^m   Pannozzo, Fabio ⁿ   Piffer, Silvano ^o   Puppo, Antonella ^p   Tisano, Francesco ^q   Zappa, Marco ^r,s   Azzoni, A ^t   Baldazzi, P ^u   Collina, N ^u   Pandolfi, P ^u   Petrucci, C ^u   Gualandi, G ^u   Sciacchitano, S ^g   Ieni, A ^g   Bella, F ^g   Torrisi, A ^g   Varvara M ^g   Finarelli, A C ^m   De Bianchi, P Sassoli ^m   Landi, P ^m   Ferretti, S ^v   Matarese, V ^w   De Togni, A ^x   Palmonari, C ^x   Caldarella, A ^r   Crocetti, E ^r   Grazzini, G ^r   Manneschi, G ^r   Mantellini, P ^r   Serraino, D ^y   Bidoli, E ^y   Taborelli, M ^y   Gini, A ^y   Virdone, S ^y   Casella, C ^z   Celesia, M ^z   Cogno, R ^z   Marani, E ^z   Busco, S ⁿ   Bernazza, E ⁿ   Curatella, S ⁿ   Macci, L ⁿ   Rossi, M ⁿ   Randi, G ^aa   Frammartino, B ^aa   Bonini, A ^aa   Filippazzi, L ^aa   Giubelli, C ^aa   Corradini, R ^ab   De Girolamo, F ^ab   Valla, K ^h   Palombino, R ^ac   D'Orsi, M ^ac   Isernia, M ^ac   Fusco, M ^j   Vitale, F M ^j   Adamo, M S ^ad   Amodio, R ^ad   Brucculeri, A ^ad   Guttadauro, A ^ad   Mazzucco, W ^ad   Sgarzi, P ^ae   Bozzani, F ^ae   Zatelli, M ^af   Zurlini, C ^af   Caruana, P ^ag   Borciani, E ^ah   Gatti, G ^ah   Prazzoli, R ^ah   Seghini, P ^ah   Campari, C ^l   Di Felice, E ^b   Sacchettini, C ^b   Cassetti, T ^b   Falcini, F ^ai   Mancini, S ^ai   Vattiato, R ^ai   Giuliani, O ^ai   Caprara, L ^aj   Cesaraccio, R ^f   Sechi, O ^f   Madeddu, A ^q   Contrino, M L ^q   Colanino Ziino, A ^q   Russo, M ^q   Fanetti, A C ^ak   Maspero, S ^ak   Moroni, E ^ak   Cometti, I ^ak   Gentilini, M ^o   De Pretis, G ^al   Caciagli, P ^am   Pertile, R ^am   Bianconi, F ^an   Masanotti, G M ^an   De Lio, M C ^an   Leite, S ^ao   Passamonti, B U ^ap   Dei Tos, A P ^a   Rosano, A ^a   Monetti, D ^a   Guzzinati, S ^a   Tognazzo, S ^a   more..

^a Registro Tumori del Veneto   (Italy)

^b Ospedale di Reggio Emilia   (Italy)

^c Associazione Italiana Registri Tumori (AIRTUM)   (Italy)

^d S MARIA NUOVA HOSPITAL   (Italy)

^e Gruppo Italiano Screening Colorettale (GISCoR)   (Italy)

^f Registro Tumori della Provincia di Sassari   (Italy)

^g Registro Tumori Integrato di Catania Messina ^*  (Italy)

^h Registro Tumori di Modena   (Italy)

ⁱ Registro Tumori della Mammella di Palermo   (Italy)

^j Registro tumori di popolazione Regione Campania   (Italy)

^k Registro Tumori Piemonte   (Italy)

^l PATHOLOGY UNIT   (Italy)

^m Servizio Presidi Ospedalieri Assessorato Politiche per la Salute Emilia Romagna   (Italy)

ⁿ Registro Tumori di Popolazione della Provincia di Latina   (Italy)

^o Registro Tumori della Provincia di Trento   (Italy)

^p Regione Liguria   (Italy)

^q Registro Tumori di Siracusa   (Italy)

^r Istituto per Lo Studio e la Prevenzione Oncologica ISPO   (Italy)

^s Osservatorio Nazionale Screening (ONS)   (Italy)

^t ASL Biella   (Italy)

^u Registro Tumori di Bologna   (Italy)

^v Rewgistro Tumori di Ferrara   (Italy)

^w UO Neurologia   (Italy)

^x Centro Screening Oncologici AUSL Ferrara   (Italy)

^y CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^z UNIVERSITY OF GENOA   (Italy)

^aa Istituto Del Tumori di Milano   (Italy)

^ab AUSL Modena   (Italy)

^ac ASL Napoli 3 Sud   (Italy)

^ad UNIVERSITY OF PALERMO   (Italy)

^ae Registro Tumori Provincia Parma   (Italy)

^af Centro Screening Oncologici AUSL   (Italy)

^ag AOU Parma   (Italy)

^ah AUSL Piacenza   (Italy)

^ai NATIONAL CANCER INSTITUTE   (Italy)

^aj Anatomia Patoligica OC SM della Scaletta   (Italy)

^ak Registro Tumori della Provincia di Sondrio   (Italy)

^al SANTA CHIARA HOSPITAL   (Italy)

^am APSS   (Italy)

^an UNIVERSITY OF PERUGIA   (Italy)

^ao F La Rosa Registro Tumori Umbro   (Italy)

^ap Servizio di Screening USL 1 Umbria   (Italy)

more..

Author keywords

Colorectal cancer; Fecal immunochemical test; Incidence rates; Italy; Screening

Indexed keywords

ADULT; AGED; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; ITALY; MALE; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; OCCULT BLOOD; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; ITALY; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD;

EID: 85016104155     PISSN: 11209763     EISSN: 23851937     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. AIOM-AIRTUM. I numeri del cancro in Italia 2014. Brescia, Intermedia Editore 2014.
2. ITACAN: Tumori in Italia, Versione 2.0. AIRTUM. Available at: http://www.registri-tumori.it [Accessed November 24, 2014].
3. Baracco M, Barizza F, Bovo E et al. Fatti e cifre dei tumori in Veneto. Colon retto. Padova 2007. Available at: http://www.registrotumoriveneto. it/registro/analisi/file/FATTI-E-CIFRE-DEI-TUMORI-colon-retto-definitivo.pdf [Accessed November 24, 2014].
4. Mangone L et al. I tumori in provincia di Reggio Emilia nel periodo 1996-2003. Collana Progetto Salute 9, AUSL Reggio Emilia.
5. Ponz de Leon M, Benatti P et al. Epidemiologia dei Tumori del colon-retto. Incidenza, mortalità, familiarità e sopravvivenza nella ex USL di Modena, 1984-1998. Università di Modena, Modena 2001.
6. Ward KC, Young JL, Ries L A G. Cancers of the colon and rectum. In: Ries LAG, Young JL, Keel GE et al eds. SEER survival monograph: cancer survival amongst adults: U. S. SEER Program, 1998-2001, patient and tumor characteristics. NIH Pub. No. 07-6215. Bethesda, Md, National Institutes of Health 2007:33-42.
7. Ries L A G, Wingo PA, Miller DS et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000;88:2398-424.
8. AIRTUMWorking Group. Italian cancer figures - Report 2011. Survival of cancer patients in Italy. Epidemiol Prev 2011;5-6(Suppl 3):85.
9. Zorzi M, Fedato C, Grazzini G et al. Screening for colorectal cancer in Italy, 2010 survey. Epidemiol Prev 2012;6(Suppl 1):55-77.
10. ZorziM, Baracco S, Fedato C et al. Screening for colorectal cancer in Italy, 2009 survey. Epidemiol Prev 2011;5-6(Suppl 5):55-77.
11. ZorziM, Baracco S, Fedato C et al. Screening for colorectal cancer in Italy: 2006 survey. Epidemiol Prev 2008;2(Suppl 1):55-68.
12. Hewitson P, Glasziou P et al. Cochrane systematic reviewof colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008;103(6):1541-49.
13. Costantini AS, Martini A, Puliti D et al. Colorectal cancer mortality in two areas of Tuscany with different screening exposures. J Natl Cancer Inst 2008;100(24):1818-21.
14. Zorzi M, Fedeli U, Schievano E et al. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test. Gut 2014 Sep. 1. pii: gutjnl-2014-307508. doi: 10.1136/gutjnl-2014-307508.
15. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
16. Mandel JS, Church TR, Bond JH et al. The effect of fecal occultblood screening on the incidence of colorectal cancer. N Engl JMed 2000;343:1603-607.
17. Kronborg O, Jorgensen OD, Fenger C et al. Randomized study of biennial screening with a faecal occult blood test: Results after nine screening rounds. Scand J Gastroenterol 2004;39:846-51.
18. Kewenter J, Brevinge H, Engaras B et al. Results of screening, rescreening, and follow-up in a prospective, randomized study for the detection of colorectal cancer by fecal occult blood testing. Results for 68308 subjects. Scand J Gastroenterol 1994;29:468-73.
19. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-77.
20. Ventura L, Mantellini P, Grazzini G et al. The impact of immunochemical faecal occult blood testing on colorectal cancer incidence. Dig Liver Dis 2013 Sep. 3. doi: pii: S1590-8658 (13) 00280-6. 10.1016/j.dld.2013.07.017.
21. Allison JE, Tekawa IS, Ransom LJ et al. A comparison of fecal occult-blood tests for colorectal cancer screening. N Engl J Med 1996;334(3):155-59.
22. Allison JE, Sakoda LC, Levin TR et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007;99(19):1462-70.
23. Guittet L, Bouvier V, Mariotte N et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007;56(2):210-14.
24. Hol L, van Leerdam ME, van Ballegooijen M et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59(1):62-68.
25. Hol L, Wilschut JA, van BM et al. Screening for colorectal cancer: randomcomparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009;100(7):1103-10.
26. van Rossum LG, van Rijn AF, Laheij RJ et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135(1):82-90.
27. Kronborg O, Fenger C, Olsen J et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348(9040):1467-71.
28. AIRTUM Working Group. I trend dei tumori in Italia negli anni duemila (1998-2005). Cancer trend (1998-2005). Epidemiol Prev 2009;4-5(Suppl. 1):1-165
29. Morrison AS. Screening in Chronic Disease, 2nd ed. New York, Oxford University Press 1992.
30. Wong MC, Ching JY, Chan VC et al. Factors associated with falsepositive and false-negative fecal immunochemical test results for colorectal cancer screening. Gastrointest Endosc 2014 Oct. 4. pii: S0016-5107 (14) 02075-6. doi: 10.1016/j.gie.2014.08.006.
31. Brenner H, Altenhofen L, Stock C, Hoffmeister M. Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany. Clin Gastroenterol Hepatol 2015;13(4):717-23. pii: S1542-3565 (14) 01313-5. doi: 10.1016/j.cgh.2014.08.036. [Epub 2014 Sept 15]
32. Esserman LJ, Thompson IM Jr, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 2018;310(8):797-98.
33. Holme Ø, Bretthauer M, Fretheim A et al. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev 2013 Oct. 1;9:CD009259. doi: 10.1002/14651858. CD009259.pub2.
34. Yang DX1, Gross CP, Soulos PR, Yu JB. Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009. Cancer 2014;120(18):2893-901. doi:10.1002/cncr.28794
35. Atkin WS, Edwards R, Kralj-Hans I et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
36. Segnan N, Armaroli P, Bonelli L et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer Inst 2011;103:1310-22.
37. Haug U, Knudsen AB, Brenner H, Kuntz KM. Is fecal occult blood testing more sensitive for left-versus right-sided colorectal neoplasia? A systematic literature review. Expert Rev Mol Diagn 2011;11(6):605-16.
38. Singh S, Singh PP, Murad MH et al. Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysis. Am J Gastroenterol 2014 Sep; 109(9):1375-89. doi: 10.1038/ajg.2014.171. Epub 2014 Jun. 24. Review. PubMed PMID: 24957158.
39. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 2003;139(6):846-52.